Quantum量子訊息有限公司
← 最新全球產業報告

U.S. Women’s Health Charitable Giving Market

研究執行與發布:Verified Market Research · 發布日期 2026-01-20 · 150 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

出版商 Verified Market Research產業別 Healthcare & Life Sciences出版日期 2026-01-20頁數 150報告編號 541673

授權報價

Single User$3,950 USD
Multi User$4,850 USD
Enterprise / Global Site Licence$7,550 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
U.S. Women’s Health Charitable Giving Market Size By Disease Type (Cancers, Breast Cancer), By Donor Type (Individuals, High-Net-Worth Donors), By Geographic Scope And Forecast

報告摘要

U.S. Women’s Health Charitable Giving Market Size And Forecast U.S. Women’s Health Charitable Giving Market size was valued at USD 12,108.05 Million in 2024 and is projected to reach USD 20,328.39 Million by 2032, growing at a CAGR of 6.73% from 2025 to 2032. Persistent gender health gaps in areas like maternal health, reproductive rights, and gender-based violence drive increased donor focus and funding, as addressing these issues is recognized as both a social and economic imperative, growing coalitions of philanthropists and influential women-led initiatives are mobilizing substantial capital to provide flexible, multi-year funding targeting systemic women’s health challenges are the factors driving the market growth. The U.S. Women’s Health Charitable Giving Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. U.S. Women’s Health Charitable Giving Market Definition Women’s health charitable giving refers to the organized flow of donations, grants, endowments, and philanthropic commitments directed toward improving physical, mental, and social health outcomes specifically for women across different stages of life. At its core, it captures an intentional focus on conditions that disproportionately or uniquely affect women, such as maternal health, reproductive care, gynaecological cancers, menopause management, autoimmune disorders with a higher female prevalence, mental-health disparities, and the systemic barriers that continue to influence diagnostics, treatment access, and long-term wellbeing. Unlike general health philanthropy, this category recognizes that women’s health is shaped by biology, gender norms, and structural inequalities, and therefore requires dedicated funding streams. Many donors see this space as an opportunity to close long-standing research gaps, support preventive education, and ensure that vulnerable groups, rural women, low-income communities, minority populations, and survivors of violence receive equitable care. Women’s health charitable giving also includes support for the institutions and ecosystems that deliver care. This can involve funding hospitals, clinics, and mobile health units, particularly those that specialize in OB/GYN services, maternal-fetal health, or breast and cervical cancer screenings. It can also include investments in community health workers, midwives, nurses, and local organizations that build trust within underserved neighborhoods. Donors frequently support training programs that strengthen the skills of frontline workers who interact with women during the most vulnerable moments of their lives, pregnancy, childbirth, postnatal recovery, chronic disease management, or treatment for gender-based violence. For centuries, women's health has been marginalized, with their symptoms often dismissed, their pain minimized, and their specific health concerns under-prioritized in both public funding and private research agendas. Charitable giving, therefore, serves as a crucial corrective force, enabling individuals and institutions to directly address these gaps and accelerate progress where systemic responses have been slow or inadequate. It is a powerful tool for advocacy, as the collective weight of donations sends an unambiguous market signal about what issues matter to the public. This funding often serves as risk capital for innovative pilot programs and grassroots organizations that are nimble, culturally competent, and deeply embedded within the communities they serve, often achieving results that larger, more bureaucratic systems cannot. U.S. Women’s Health Charitable Giving Market Overview The U.S. Women’s Health Charitable Giving Market represents a dynamic and critically important segment of the American philanthropic landscape. Historically, women's health issues have been underfunded and overlooked, both in public funding and private investment. However, a significant shift has been underway over the past decade. Donors are increasingly recognizing that investing in women's health yields profound societal benefits, impacting not only individual wellbeing but also economic productivity, family stability, and community resilience. The market is characterized by a diverse ecosystem of nonprofit organizations, ranging from large, established foundations to grassroots, community-based groups. These entities focus on a broad spectrum of issues, including but not limited to reproductive health and rights, maternal mortality, breast and gynecological cancers, menopause, endometriosis, and mental health. The overarching trend is a move from a narrow, disease-specific focus toward a more holistic understanding of women’s health across the entire lifespan, driven by a growing body of research and powerful advocacy from patients and healthcare professionals. Demographic and epidemiological shifts drive philanthropic funding for women’s health. An aging population and rising prevalence of chronic conditions (cardiometabolic disease, breast and gynecologic cancers, reproductive health complications) increase visible need and sympathetic giving. Growing public awareness and destigmatization sparked by advocacy campaigns, survivors’ stories, and influencer-driven conversations have broadened donor interest beyond traditional maternal health to menopause, mental health, and women’s needs. The giving to women’s and girls’ organizations remains a small share of total U.S. philanthropy despite growth; funding is fragmented across thousands of small organizations and competes with larger, better-funded sectors (religion, education, health broadly), making scale-up and sustained program financing difficult. That fragmentation raises transaction costs for large donors and risks duplicative services rather than consolidated impact. Economic uncertainty and fluctuations in disposable income directly impact individual donation levels, making it difficult for many organizations to maintain consistent revenue streams. The expansion of digital and peer-to-peer fundraising platforms allows organizations to engage new, younger demographics and facilitate micro-donations. There is considerable potential in engaging younger demographics, such as Millennials and Gen Z, by leveraging social media storytelling and transparent impact reporting. Expanding the scope of giving to include historically underfunded areas, such as mental health and endometriosis, can attract new donor interest. There is also significant opportunity to increase funding for historically underfunded areas beyond reproductive health, such as cardiovascular disease and mental wellness in women. Forming strategic partnerships with for-profit corporations focused on Environmental, Social, and Governance (ESG) goals can unlock new corporate sponsorship and cause-related marketing avenues. Based on Donor Type, the market is segmented into Individuals, Foundations, Corporations, Bequests. In 2024, Individuals segment accounted for the largest market share. U.S. Women’s Health Charitable Giving Market Segmentation Analysis The U.S. Women’s Health Charitable Giving Market is segmented based on Disease Type, Donor Type and Geography. U.S. Women’s Health Charitable Giving Market, By Disease Type Cancers Reproductive & Maternal Health Mental Health & Wellbeing Chronic & Non-Communicable Diseases Breast Cancer Others Based on Disease Type, the market is segmented into Cancers, Breast Cancer, Chronic & Non-Communicable Diseases, Reproductive & Maternal Health, Mental Health & Wellbeing, Others. Cancers accounted for the largest market share of 35.28% in 2023, with a market value of USD 4,272.03 Million and is projected to grow at a CAGR of 7.07% during the forecast period. U.S. Women’s Health Charitable Giving Market, By Donor Type Individuals High-Net-Worth Donors Foundations Corporations Bequests Based on Donor Type, the market is segmented into Individuals, High-Net-Worth Donors, Foundations, Corporations, Bequests. Individuals accounted for the largest market share of 66.30% in 2023, with a market value of USD 8,028.02 Million and is projected to grow at a CAGR of 6.78% during the forecast period. U.S. Women’s Health Charitable Giving Market, By Geography U.S. Based on Regional Analysis, the market is segmented into U.S. Key Players Several manufacturers involved in the U.S. Women’s Health Charitable Giving Market boost their industry presence through partnerships and collaborations. Over the anticipated timeframe, new entrants will grow steadily, powered by substantial profit margins. The major players in the market include Ford Foundation, Gates Foundation, The David and Lucile Packard Foundation, The Conrad N. Hilton Foundation, WOMEN’S HEALTH ACCESS MATTERS, Planned Parenthood Federation of America Inc., American College of Obstetricians and Gynecologists, Magee-Womens Institute & Foundation, Covenant House International, Shoppers Drug Mart Inc., Provide Inc., and Save the Storks. This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with Coating Type benchmarking and SWOT analysis. Ace Matrix Analysis This section of the report provides an overview of the company evaluation scenario in the U.S. Women’s Health Charitable Giving Market. The company evaluation has been carried out based on the outcomes of the qualitative and quantitative analyses of various factors such as product portfolios, technological innovations, market presence, revenues of companies, and the opinions of primary respondents.
目錄 Table of Contents
1 INTRODUCTION 1.1 MARKET DEFINITION 1.2 MARKET SEGMENTATION 1.3 RESEARCH TIMELINES 1.4 ASSUMPTIONS 1.5 LIMITATIONS 2 RESEARCH METHODOLOGY 2.1 DATA MINING 2.1.1 SECONDARY RESEARCH 2.1.2 PRIMARY RESEARCH 2.1.3 SUBJECT MATTER EXPERT ADVICE 2.1.4 QUALITY CHECK 2.1.5 FINAL REVIEW 2.2 DATA TRIANGULATION 2.3 BOTTOM-UP APPROACH 2.4 TOP-DOWN APPROACH 2.5 RESEARCH FLOW 2.6 DATA SOURCES 3 EXECUTIVE SUMMARY 3.1 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET OVERVIEW 3.2 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET ESTIMATES AND FORECAST (USD MILLION), 2023-2032 3.3 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET ECOLOGY MAPPING 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM 3.5 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET ABSOLUTE MARKET OPPORTUNITY 3.6 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET, BY DISEASE TYPE (USD MILLION) 3.7 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET, BY DONOR TYPE (USD MILLION) 3.8 FUTURE MARKET OPPORTUNITIES 4 MARKET OUTLOOK 4.1 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET EVOLUTION 4.2 UNITED STATES WOMEN’S HEALTH CHARITABLE GIVING MARKET OUTLOOK 4.3 MARKET DRIVERS 4.3.1 PERSISTENT GENDER HEALTH GAPS IN AREAS LIKE MATERNAL HEALTH, REPRODUCTIVE RIGHTS, AND GENDER-BASED VIOLENCE DRIVE INCREASED DONOR FOCUS AND FUNDING, AS ADDRESSING THESE ISSUES IS RECOGNIZED AS BOTH A SOCIAL AND ECONOMIC IMPERATIVE 4.3.2 GROWING COALITIONS OF PHILANTHROPISTS AND INFLUENTIAL WOMEN-LED INITIATIVES ARE MOBILIZING SUBSTANTIAL CAPITAL TO PROVIDE FLEXIBLE, MULTI-YEAR FUNDING TARGETING SYSTEMIC WOMEN’S HEALTH CHALLENGES. 4.4 MARKET RESTRAINTS 4.4.1 CHRONIC UNDERFUNDING PERSISTS, WITH WOMEN’S HEALTH RECEIVING ONLY ABOUT 2% OF TOTAL PHILANTHROPIC DONATIONS, LEAVING MANY CRITICAL AREAS LIKE AUTOIMMUNE DISEASES AND MENTAL HEALTH UNDERSERVED. 4.4.2 VOLATILITY IN GOVERNMENT POLICIES AND FUNDING CUTS CAN DISRUPT NONPROFIT ACTIVITIES AND LIMIT THE IMPACT OF PHILANTHROPY, ESPECIALLY WHEN PUBLIC SECTOR SUPPORT DIMINISHES. 4.5 MARKET OPPORTUNITIES 4.5.1 TARGETING UNDERFUNDED CONDITIONS SUCH AS MENTAL HEALTH AND MENOPAUSE-RELATED HEALTHCARE PRESENTS SIGNIFICANT POTENTIAL FOR NEW DONOR ENGAGEMENT AND IMPACT SCALING 4.5.2 LEVERAGING DIGITAL HEALTH INNOVATIONS, INCLUDING TELEHEALTH AND AI-DRIVEN DIAGNOSTICS, CAN EXTEND PHILANTHROPIC REACH AND IMPROVE OUTCOMES FOR UNDERSERVED WOMEN’S POPULATIONS 4.6 MARKET TRENDS 4.6.1 AN INCREASE IN WOMEN-LED PHILANTHROPY AND VENTURE CAPITAL FUNDING IS RESHAPING THE FUNDING LANDSCAPE, FOSTERING STRATEGIC, LONG-TERM INVESTMENTS RATHER THAN ONE-OFF CONTRIBUTIONS 4.6.2 COLLABORATIVE PHILANTHROPY MODELS AND DONOR COALITIONS ARE GROWING, ENABLING MORE COORDINATED EFFORTS AND LARGER UNRESTRICTED GRANTS TO WOMEN’S HEALTH ORGANIZATIONS DRIVING SYSTEMIC CHANGE 4.7 PORTER’S FIVE FORCES ANALYSIS 4.7.1 THREAT OF NEW ENTRANTS: MODERATE 4.7.2 THREAT OF SUBSTITUTES: MODERATE 4.7.3 BARGAINING POWER OF DONORS: HIGH 4.7.4 BARGAINING POWER OF SERVICE PROVIDERS: MODERATE 4.7.5 INTENSITY OF COMPETITIVE RIVALRY: HIGH 4.8 DEMOGRAPHIC ANALYSIS 4.8.1 AGE 4.8.2 GENDER 4.8.3 RACE/HERITAGE/CULTURAL BACKGROUND 4.8.4 GEOGRAPHICAL 4.9 PSYCHOGRAPHIC ANALYSIS 4.9.1 LIFESTYLE 4.9.2 ATTITUDES 4.9.3 VALUES 4.9.4 INTERESTS 4.10 BEHAVIORAL ANALYSES 4.10.1 GIVING FREQUENCY 4.10.2 DONATION METHOD 4.10.3 ENGAGEMENT LEVEL 4.11 ESTIMATED DATA GRAPHS FOR BEHAVIORAL, PSYCHOGRAPHIC & DEMOGRAPHIC SECTIONS 5 MARKET, BY DISEASE TYPE 5.1 OVERVIEW 5.2 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY DISEASE TYPE 5.3 CANCERS 5.4 REPRODUCTIVE & MATERNAL HEALTH 5.5 MENTAL HEALTH & WELLBEING 5.6 CHRONIC & NON-COMMUNICABLE DISEASES 5.7 BREAST CANCER 5.8 OTHERS (AUTOIMMUNE DISEASES, INFECTIOUS DISEASES, VIOLENCE-RELATED HEALTHCARE) 6 MARKET, BY DONOR TYPE 6.1 OVERVIEW 6.2 U.S. WOMEN’S HEALTH CHARITABLE GIVING MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY DONOR TYPE 6.3 INDIVIDUALS 6.4 FOUNDATIONS 6.5 CORPORATIONS 6.6 BEQUESTS 6.7 HIGH-NET-WORTH DONORS 7 MARKET, BY GEOGRAPHY 7.1 U.S. 7.1.1 U.S. MARKET SNAPSHOT 8 COMPETITIVE LANDSCAPE 8.1 OVERVIEW 8.2 COMPANY MARKET RANKING ANALYSIS 8.3 COMPANY INDUSTRY FOOTPRINT 8.4 ACE MATRIX 8.4.1 ACTIVE 8.4.2 CUTTING EDGE 8.4.3 EMERGING 8.4.4 INNOVATORS 9 COMPANY PROFILE 9.1 FORD FOUNDATION 9.1.1 COMPANY OVERVIEW 9.1.2 COMPANY INSIGHTS 9.1.3 SERVICE BENCHMARKING 9.1.4 WINNING IMPERATIVES 9.1.5 CURRENT FOCUS & STRATEGIES 9.1.6 THREAT FROM COMPETITION 9.1.7 SWOT ANALYSIS 9.2 GATES FOUNDATION 9.2.1 COMPANY OVERVIEW 9.2.2 COMPANY INSIGHTS 9.2.3 SERVICE BENCHMARKING 9.2.4 KEY DEVELOPMENTS 9.2.5 WINNING IMPERATIVES 9.2.6 CURRENT FOCUS & STRATEGIES 9.2.7 THREAT FROM COMPETITION 9.2.8 SWOT ANALYSIS 9.3 THE DAVID AND LUCILE PACKARD FOUNDATION 9.3.1 COMPANY OVERVIEW 9.3.2 COMPANY INSIGHTS 9.3.3 SERVICE BENCHMARKING 9.3.4 KEY DEVELOPMENTS 9.4 THE CONRAD N. HILTON FOUNDATION 9.4.1 COMPANY OVERVIEW 9.4.2 COMPANY INSIGHTS 9.4.3 SERVICE BENCHMARKING 9.4.4 KEY DEVELOPMENTS 9.5 WOMEN’S HEALTH ACCESS MATTERS 9.5.1 COMPANY OVERVIEW 9.5.2 COMPANY INSIGHTS 9.5.3 SERVICE BENCHMARKING 9.6 PLANNED PARENTHOOD FEDERATION OF AMERICA INC. 9.6.1 COMPANY OVERVIEW 9.6.2 COMPANY INSIGHTS 9.6.3 BUSINESS BREAKDOWN 9.6.4 SERVICE BENCHMARKING 9.6.5 WINNING IMPERATIVES 9.6.6 CURRENT FOCUS & STRATEGIES 9.6.7 THREAT FROM COMPETITION 9.6.8 SWOT ANALYSIS 9.7 AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS 9.7.1 COMPANY OVERVIEW 9.7.2 COMPANY INSIGHTS 9.7.3 SERVICE BENCHMARKING 9.8 MAGEE-WOMENS INSTITUTE & FOUNDATION 9.8.1 COMPANY OVERVIEW 9.8.2 COMPANY INSIGHTS 9.8.3 SERVICE BENCHMARKING 9.8.4 KEY DEVELOPMENTS 9.9 COVENANT HOUSE INTERNATIONAL 9.9.1 COMPANY OVERVIEW 9.9.2 COMPANY INSIGHTS 9.9.3 SERVICE BENCHMARKING 9.10 SHOPPERS DRUG MART INC. 9.10.1 COMPANY OVERVIEW 9.10.2 COMPANY INSIGHTS 9.10.3 SERVICE BENCHMARKING 9.11 PROVIDE INC. 9.11.1 COMPANY OVERVIEW 9.11.2 COMPANY INSIGHTS 9.11.3 SERVICE BENCHMARKING 9.12 SAVE THE STORKS 9.12.1 COMPANY OVERVIEW 9.12.2 COMPANY INSIGHTS 9.12.3 SERVICE BENCHMARKING 9.12.4 KEY DEVELOPMENTS

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Verified Market Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們